History
  • No items yet
midpage
United States v. Kosinski
976 F.3d 135
2d Cir.
2020
Read the full case

Background

  • Dr. Edward Kosinski was a principal investigator in a Phase III clinical trial for Regado Biosciences (REG1) and signed confidentiality and clinical-study agreements (CDA and CSRA) that required maintaining study information in strict confidence and promptly disclosing Regado stock holdings over $50,000 (Form FDA 1572).
  • While serving as an investigator, Kosinski secretly accumulated roughly $250,000 of Regado stock, did not disclose the holdings, and falsely told St. Vincent’s he owned no Regado shares in a site-application form.
  • After receiving confidential, nonpublic trial notices (a June 29 e‑mail pausing enrollment for allergic reactions; a July 29 e‑mail reporting a patient death), Kosinski sold all his shares (avoiding ≈$160,000 loss) and later purchased puts and traded to realize ≈$3,300 profit when the trial was publicly terminated.
  • FBI interviews captured Kosinski admitting the trades were motivated by "greed and stupidity" and that he felt bad about them; he filed an updated FDA Form 1572 only after the study ended.
  • Indicted under §10(b)/Rule 10b‑5 (misappropriation theory), Kosinski was convicted on two counts, sentenced principally to six months’ imprisonment, and appealed arguing no duty not to trade and insufficient willfulness.

Issues

Issue Gov't's Argument Kosinski's Argument Held
Whether Kosinski owed a duty not to trade on confidential study information He was a temporary insider/ fiduciary to Regado by agreement and role; misappropriation of confidential information violates §10(b) The CSRA only required confidentiality of information, not a prohibition on trading; he was an independent contractor and owed no fiduciary duty Court: Kosinski was a temporary insider with a fiduciary‑like duty; failure to disclose and trading satisfied misappropriation liability (affirmed)
Whether the CSRA’s confidentiality language alone creates a duty The agreement (and FDA disclosure rule) and the nature of the PI role create a duty of trust and confidence Confidentiality clause without explicit anti‑trading language is insufficient; arm’s‑length/independent‑contractor label prevents fiduciary status Court: Express agreement to keep information confidential and the PI relationship are sufficient to establish a duty; contractual label does not defeat public‑policy based insider‑trading rules
Whether the jury instruction on willfulness was legally sufficient and whether evidence proved willfulness Willfulness requires knowledge that conduct is unlawful in general, not knowledge of a specific statute; evidence (sophisticated trader, lies, admissions) shows willfulness The instruction failed to require awareness that conduct violated securities laws; evidence insufficient under a stricter standard Court: Instruction consistent with Bryan and precedent; no reversible error and evidence supported willfulness beyond a reasonable doubt (affirmed)
Whether exclusion of two post‑/pre‑indictment statements violated rule of completeness or hearsay exceptions Statements were not admissible as excited utterances and not required to complete the admitted statements The excluded remarks (had not retained counsel; “I can’t believe this is happening”) were admissible to contextualize his admissions Court: Exclusion was not an abuse of discretion; hearsay/excited‑utterance and completeness grounds fail (no reversible error)

Key Cases Cited

  • Dirks v. SEC, 463 U.S. 646 (1983) (temporary insiders and fiduciary duty concept)
  • United States v. O’Hagan, 521 U.S. 642 (1997) (misappropriation theory of insider trading)
  • Chiarella v. United States, 445 U.S. 222 (1980) (insider duty to disclose or abstain)
  • United States v. Falcone, 257 F.3d 226 (2d Cir. 2001) (fiduciary/functional‑equivalent duty for misappropriation liability)
  • United States v. Chestman, 947 F.2d 551 (2d Cir. 1991) (temporary insider/fiduciary factors discussion)
  • United States v. Martoma, 894 F.3d 64 (2d Cir. 2017) (sufficiency review and insider‑trading principles)
  • Bryan v. United States, 524 U.S. 184 (1998) (willfulness defined as acting with bad purpose; knowledge of illegality generally sufficient)
  • Jackson v. Virginia, 443 U.S. 307 (1979) (standard for sufficiency of evidence)
Read the full case

Case Details

Case Name: United States v. Kosinski
Court Name: Court of Appeals for the Second Circuit
Date Published: Sep 22, 2020
Citation: 976 F.3d 135
Docket Number: 18-3065
Court Abbreviation: 2d Cir.